The recent study published in Health Affairs highlights the limited effects of the new risk-adjustment model on Medicare Advantage.
Despite expectations, the findings show that benefits have remained largely unchanged during the 2024-25 timeframe.
This outcome raises questions about the effectiveness of the model in addressing the complexities of Medicare Advantage.